Kazuo Hattori Selected Research

2',3'- O- diacetyl- 5'- deoxy- 5- vinylcytidine

9/2003	Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889.
3/2003	Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuo Hattori Research Topics

Disease

3	Neoplasms (Cancer) 04/2007 - 03/2003
1	Fibroma (Fibromatosis) 01/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Neurofibroma 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 09/2003

Drug/Important Bio-Agent (IBA)

2	ProdrugsIBA 04/2007 - 03/2003
2	5-vinyluracilIBA 09/2003 - 03/2003
2	2',3'- O- diacetyl- 5'- deoxy- 5- vinylcytidineIBA 09/2003 - 03/2003
2	Capecitabine (Xeloda)FDA Link 09/2003 - 03/2003
2	Fluorouracil (Carac)FDA LinkGeneric 09/2003 - 03/2003
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 09/2003 - 03/2003
1	Anesthetics (Anesthetic Agents)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 04/2007
1	2'-deoxy-2'-methylenecytidineIBA 04/2007
1	DipeptidesIBA 04/2007
1	dipeptidaseIBA 04/2007
1	Complementary DNA (cDNA)IBA 09/2003
1	eniluracilIBA 09/2003
1	EnzymesIBA 03/2003
1	Thymidine PhosphorylaseIBA 03/2003
1	Cytidine DeaminaseIBA 03/2003
1	EsterasesIBA 03/2003

Therapy/Procedure

1	Spinal Anesthesia 01/2016
1	General Anesthesia 01/2016
1	Therapeutics 03/2003